Effects of telmisartan on office and 24-hour ambulatory blood pressure: An observational study in hypertensive patients managed in primary care

Vascular Health and Risk Management

Volumn 6, Issue 1, 2010, Pages 31-38

  Kontny, Frederic ^a   Risanger, Terje ^b   Bye, Arne ^c   Arnesen, Øyvind ^d   Johansen, Odd Erik ^d   Bakken, J ^e   Baloch, S M ^e   Berz, A ^e   Blatter Krog, Strømme M ^e   Bye, A ^e   D'Angelo, G E ^e   Folven, A ^e   Gorski, Z ^e   Humborstad, B J ^e   Karsten, D O ^e   Langaker, K E ^e   Landmark, N E ^e   Leraand, N ^e   Lunde, S ^e   Nicolaisen, B ^e   Onsum, H ^e   Parvaiz, R ^e   Risanger, T ^e   Raheim G A ^e   Storvand, E ^e   Ulvan, M ^e   Walaas, K ^e   Wear Hansen, H G ^e   Wessel Aas, T ^e   Aaserud, E ^e   more..

^a Volvat Medical Centre   (Norway)

^b Prinsdal Health Centre   (Norway)

^c Frosta Health Centre   (Norway)

^d Medical Department   (Norway)

^e NONE

Author keywords

24 hour ambulatory blood pressure; Efficacy; Observational study; Telmisartan; Tolerability

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; HYDROCHLOROTHIAZIDE PLUS TELMISARTAN; TELMISARTAN;

ADULT; ARTHRALGIA; ARTICLE; BLOOD PRESSURE MONITORING; BRONCHITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; ENTERITIS; ESSENTIAL HYPERTENSION; FATIGUE; FEMALE; HUMAN; HYPOTENSION; LETHARGY; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; MULTICENTER STUDY; OBSERVATIONAL STUDY; POLLAKISSURIA; PRIMARY MEDICAL CARE; RHINITIS; SYSTOLIC BLOOD PRESSURE; XEROSTOMIA;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES;

EID: 77950807400     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Selmer R. Blood pressure and twenty-year mortality in the City of Bergen, Norway. Am J Epidemiol. 1992;136:428-440.
2. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.
3. Wang TJ, Vasan RS. Epidemiology of uncontrolled hypertension in the United States. Circulation. 2005;112:1651-1662.
4. Peterson JC, Adler S, Burkart JM, et al. Blood pressure control, proteinuria, and the progression of renal disease: The Modification of Diet in Renal Disease Study. Ann Intern Med. 1995;123:754-762.
5. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199-206.
6. Fields LE, Burt VL, Cutler JA, et al. The burden of adult hypertension in the United States 1999 to 2000: A rising tide. Hypertension. 2004;44:398-404.
7. Ostchega Y, Dillon CF, Hughes JP, et al. Trends in hypertension prevalence, awareness, treatment, and control in Older US Adults: Data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc. 2007;55:1056-1065.
8. Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
9. Rosendorff C, Black HR, Cannon CP, et al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation. 2007;115:2761-2788.
10. Task FM, Mancia G, De Backer G, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28:1462-1536.
11. Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA. 2003;289:2534-2544.
12. Geller JC, Cassens S, Brosz M, et al. Achievement of guideline-defined treatment goals in primary care: the German Coronary Risk Management (CoRiMa) study. Eur Heart J. 2007;28:3051-3058.
13. Nieto FJ, Alonso J, Chambless LE, et al. Population awareness and control of hypertension and hypercholesterolemia. The Atherosclerosis Risk in Communities study. Arch Intern Med. 1995;155:677-684.
14. Tanaka T, Okamura T, Yamagata Z, et al. Awareness and treatment of hypertension and hypercholesterolemia in Japanese Workers: The High-Risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) Study. Hypertens Res. 2007;30:921-928.
15. Sharpe M, Jarvis B, Goa KL. Telmisartan: a review of its use in hypertension. Drugs. 2001;61:1501-1529.
16. O'Brien E, Asmar R, Beilin L, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens. 2003;21:821-848.
17. Michel MC, Bohner H, Köster J, et al. U. Safety of telmisartan in patients with arterial hypertension: an open-label observational study. Drug Saf. 2004;27:335-344.
18. White WB, Weber MA, Davidai G, et al. Ambulatory blood pressure monitoring in the primary care setting: assessment of therapy on the circadian variation of blood pressure from the MICCAT-2 Trial. Blood Press Monit. 2005;10:157-163.
19. Mallion JM, de Gaudemaris R, Baguet JP, et al. Acceptability and tolerance of ambulatory blood pressure measurement in the hypertensive patient. Blood Press Monit. 1996;1:197-203.
20. Conen D, Bamberg F. Noninvasive 24-h ambulatory blood pressure and cardiovascular disease: a systematic review and meta-analysis. J Hypertens. 2008;26:1290-1299.
21. Verdecchia P, Angeli F, Mazzotta G, et al. G. Home blood pressure measurements will not replace 24-hour ambulatory blood pressure monitoring. Hypertension. 2009;54:188-195.